PRESS RELEASE published on 05/24/2023 at 12:00, 1 year 10 months ago Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 04/27/2023 at 12:00, 1 year 11 months ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Secured Convertible Debentures for Gross Proceeds of AUD$2,400,000
PRESS RELEASE published on 04/12/2023 at 22:00, 1 year 11 months ago Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
PRESS RELEASE published on 04/04/2023 at 12:00, 2 years ago Tryp Therapeutics Completes Psychotherapy Training for Planned Phase 2a Clinical Trial at Massachusetts General Hospital
PRESS RELEASE published on 01/05/2023 at 13:00, 2 years 3 months ago Tryp Therapeutics Announces Interim Results for Its Phase II Clinical Trial for the Treatment of Binge Eating Disorder With Psilocybin-Assisted Psychotherapy
PRESS RELEASE published on 01/03/2023 at 13:00, 2 years 3 months ago Tryp Therapeutics and Massachusetts General Hospital Sign Letter of Intent for Clinical Study Investigating the Use of Psilocybin-Assisted Psychotherapy for the Treatment of Patients Suffering From Irritable Bowel Syndrome (IBS)
Published on 04/08/2025 at 15:30, 53 minutes ago Southern Energy Announces Completion of Equity Financings to Ramp Up Liquids-Rich Gas Production in a Premium-Priced U.S. Natural Gas Market
Published on 04/08/2025 at 15:10, 1 hour 13 minutes ago Focus Universal Inc. to Participate in Centri Capital Conference
Published on 04/08/2025 at 15:10, 1 hour 13 minutes ago NCMI Applauds JOGMEC investment into Rare Earth Separation and Provides Update on Accelerated Value Engineering at Lofdal Dysprosium-Terbium Project
Published on 04/08/2025 at 15:00, 1 hour 23 minutes ago Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Published on 04/08/2025 at 15:00, 1 hour 23 minutes ago Xebra Brands Reaffirms North American Strategy Following U.S. Tariff Clarity
Published on 04/08/2025 at 15:51, 31 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 04/08/2025 at 15:50, 32 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 04/08/2025 at 15:50, 32 minutes ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Published on 04/08/2025 at 15:49, 33 minutes ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Published on 04/08/2025 at 15:48, 34 minutes ago Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc
Published on 04/08/2025 at 11:00, 5 hours 23 minutes ago CNP Assurances devient le 1er assureur français au classement ESG de Sustainalytics
Published on 04/08/2025 at 11:00, 5 hours 23 minutes ago CNP Assurances becomes the 1st French insurer in the Sustainalytics ESG ranking
Published on 04/08/2025 at 08:30, 7 hours 53 minutes ago Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 31/03/2025 tot 04/04/2025
Published on 04/08/2025 at 08:30, 7 hours 53 minutes ago Cie du Bois Sauvage : Rachat d’actions propres – semaine du 31/03/2025 au 04/04/2025
Published on 04/08/2025 at 08:30, 7 hours 53 minutes ago Cie du Bois Sauvage: Buy back of own shares – week from 31/03/2025 to 04/04/2025
